ETH Zurich researchers have developed a new method of magnetic resonance imaging (MRI) for the early detection and better monitoring of multiple sclerosis (MS). The method maps the myelin sheaths in ...
Recent advances in imaging technology and artificial intelligence (AI), including machine learning (ML), have facilitated the use of optical coherence tomography (OCT), which is often combined with ...
A recent Npj Digital Medicine study assesses the accuracy and effectiveness of artificial intelligence (AI)-based imaging techniques to diagnose multiple sclerosis (MS). Study: A real-world clinical ...
"In terms of association with climate, our results suggest a relationship between enhancing lesions and tropical nights, a variable indicating extreme temperatures, which had not been previously ...
The Swoop portable MRI system showed 92% agreement with traditional MRI scans and was four times more likely to be chosen by ...
Researchers at University College London have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis ...
SHREVEPORT, La. - The Center for Molecular Imaging and Therapy, a subsidiary of BRF, proudly announces its new collaboration with the Brain Health Alliance as an imaging site in the nationwide EPSMS ...
NASHVILLE, Tennessee — A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested. Researchers ...
Please provide your email address to receive an email when new articles are posted on . Ocrelizumab reduced the number and size of MS-related cortical lesions. Data synthesis featuring a mix of ...
Hosted on MSN
Machine learning and cell imaging combine to predict effectiveness of multiple sclerosis medication
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...
Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It affects about 2.9 million people worldwide, and about 15,000 in Switzerland alone. One key feature of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results